Lung Tissue Delivery of Virus-Like Particles Mediated by Macrolide Antibiotics

Stephen N Crooke1, Jiri Schimer1,2, Idris Raji1

  • 1School of Chemistry and Biochemistry , ∥School of Biological Sciences , and §Parker H. Petit Institute for Bioengineering and Bioscience , Georgia Institute of Technology , Atlanta , Georgia 30332 , United States.

Insights

This study developed macrolide-antibiotic-linked virus-like particles (VLPs) for targeted drug delivery to lung macrophages. Azithromycin-conjugated VLPs showed enhanced uptake and lung accumulation, offering a promising platform for pulmonary infection treatments.

Area of Science:

  • Immunology
  • Nanotechnology
  • Pharmacology

Background:

  • Pulmonary macrophages are crucial for lung immunity but can harbor bacterial pathogens.
  • Bacterial infections within macrophages lead to persistent lung diseases.
  • Macrolide antibiotics accumulate in phagocytic cells, targeting lung tissues.

Purpose of the Study:

  • To develop virus-like particles (VLPs) targeted to lung macrophages using macrolide antibiotics as ligands.
  • To evaluate the efficacy of macrolide-VLP conjugates for intracellular drug delivery in pulmonary infections.

Main Methods:

  • Conjugation of macrolide antibiotics (azithromycin, clarithromycin) to virus-like particles (VLPs).
  • Assessing VLP-macrolide conjugate uptake in RAW 264.7 macrophage cell cultures.
  • Evaluating VLP biodistribution in mouse lungs following systemic injection.

Main Results:

  • VLP-macrolide conjugates demonstrated enhanced uptake in macrophage cells, with azithromycin showing the most significant effect.
  • Particle uptake induced an intermediate macrophage activation state, avoiding cytotoxicity.
  • In vivo studies showed significant VLP accumulation in mouse lungs within 2 hours of injection.

Conclusions:

  • Macrolide-functionalized VLPs represent a novel platform for targeted intracellular drug delivery to lung macrophages.
  • This approach shows potential for treating pulmonary infections by enhancing drug accumulation in infected tissues.
  • Azithromycin-conjugated VLPs are particularly effective for targeting lung-resident macrophages.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
59.5K
What are Viruses?00:50

What are Viruses?

Overview
127.8K
Subatomic Particles03:37

Subatomic Particles

Dalton was only partially correct about the particles that make up matter. All matter is composed of atoms, and atoms are composed of three smaller subatomic particles: protons, neutrons, and electrons. These three particles account for the mass and the charge of an atom.
112.4K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.4K
The Nucleosome Core Particle02:10

The Nucleosome Core Particle

Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.1K